An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Clinical trial NCT03661632 · COMPLETED
Trial details
- NCT number
- NCT03661632
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2019-11-11
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.